Risk of serious conditions reduced regardless of amount of weight lost, say researchers who compare breakthrough to discovery ...
Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular drugs Ozempic and Wegovy — could ...
Those taking the drugs for at least three years cut their risk of heart attack, stroke or cardiac death by 20 per cent ...
A recent study found that weight loss jabs can prevent heart attacks and strokes. The study found that the weight loss drug ...
“Patients taking Novo Nordisk’s Wegovy obesity treatment maintained an average of 10% weight loss after four years, ...
An obesity drug could cut heart disease and stroke risks even if you don’t lose any weight. New research has shown that ...
New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular ...
Share on Pinterest Researchers say weight-loss medications such as Ozempic can help with heart health as well as long-term ...
As a major study shows it cuts heart attack risks experts say semaglutide could 'transform many chronic diseases of ageing' ...
WOMEN taking ‘skinny jabs’ have been urged to pair them with effective contraception. It follows claims that the weight loss ...
Novo Nordisk’s diabetes drug Ozempic reduces the risk of kidney failure and death in patients who have both Type 2 diabetes ...